tyrosine has been researched along with Cancer of Kidney in 31 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 7 (22.58) | 18.2507 |
2000's | 6 (19.35) | 29.6817 |
2010's | 10 (32.26) | 24.3611 |
2020's | 8 (25.81) | 2.80 |
Authors | Studies |
---|---|
Aiglova, K; Melichar, B; Spisarova, M; Studentova, H; Szotkowski, T; Volakova, J; Zemankova, A | 1 |
Çelik, S; Demir, MK; Kılıc, T; Moujawaz, R; Öven, BB; Somay, A | 1 |
Chang, H; Qiao, Y; Shan, C; Su, M; Sun, H; Wang, J; Zhang, S; Zhao, Y | 1 |
Bielska, AA; Harrigan, CF; Kyung, YJ; Morris, Q; Palm, W; Thompson, CB | 1 |
Kanehira, M; Kato, R; Kato, Y; Maekawa, S; Matsuura, T; Obara, W; Takata, R | 1 |
Arranz Arija, JÁ; Gallardo Díaz, E; González-Del-Alba, A; Lainez-Milagro, N; Lambea Sorrosal, J; Lázaro Quintela, M; Méndez-Vidal, MJ; Peláez Fernández, I; Perez-Valderrama, B; Suárez Rodriguez, C | 1 |
Ando, K; Anzai, N; Furihata, T; Higuchi, K; Ichikawa, T; Ikehara, Y; Imamura, Y; Maimaiti, M; Matsushima, J; Nakamura, K; Okunushi, K; Reien, Y; Sakamoto, S; Sazuka, T; Takeshita, N | 1 |
Bartenstein, P; Cyran, CC; Ilhan, H; Mittlmeier, LM; Rodler, S; Staehler, M; Stief, CG; Todica, A; Unterrainer, M | 1 |
Armanini, F; Asnicar, F; Blanco-Miguez, A; Cammarota, G; Consolandi, C; Gasbarrini, A; Iacovelli, R; Ianiro, G; Lopetuso, LR; Masucci, L; Quaranta, G; Rossi, E; Sanguinetti, M; Schinzari, G; Segata, N; Settanni, CR; Thomas, AM; Tortora, G | 1 |
Li, HZ; Liu, QM; Ma, X; Wang, PC; Zhang, X; Zhang, Y; Zhu, DQ; Zhu, J | 1 |
Faridi, W; Gondal, FR; Husnain, M; Kohli, M; Malik, SU; Riaz, IB; Sipra, QUAR; Xie, H; Yadav, S | 1 |
Abu Aboud, O; Weiss, RH; Wettersten, HI | 1 |
Janovszky, A; Karg, E; László, A; Rózsa, M; Sallay, E; Tiszlavicz, L; Túri, S; Ugarte, M; Várkonyi, A; Wittmann, G | 1 |
Avril, N; Hoimes, C; Hu, L; Lee, Z; Muzic, R; Sher, A; Valls, L | 1 |
Abu Aboud, O; Bultman, S; Donohoe, D; Fitch, M; Hellerstein, M; Riiff, T; Weiss, RH | 1 |
Anastasiadis, PZ; Copland, JA; Huveldt, D; Kourtidis, A; Yanagisawa, M | 1 |
Bai, Y; Chen, YA; Dhillon, J; Fang, B; Fishman, M; Haake, SM; Haura, EB; Kinose, F; Koomen, JM; Li, J; Pow-Sang, JM; Rathmell, WK; Welsh, EA; Zent, R | 1 |
Chen, S; Guo, Z; Li, N; Xiong, K; Zhu, M; Zhuang, Z | 1 |
Berge, T; Bohman, S; Bruheim, S; Claesson-Welsh, L; Dimberg, A; Dixelius, J; Magnusson, P; Matsumoto, T; Mugishima, H; Mukhopadhyay, D; Qi, JH; Spurkland, A; Wang, L; Wernstedt, C; Wikner, C; Wu, J | 1 |
Helin, H; Hirvikoski, P; Kallio, JP; Kellokumpu-Lehtinen, P; Kinnula, LV; Martikainen, PM; Peltoniemi, M; Soini, Y; Tammela, TL | 1 |
Bergmann, S; Henklein, P; Hollenberg, MD; Junker, K; Kaufmann, R; Settmacher, U | 1 |
Helin, H; Hirvikoski, P; Kallio, JP; Kang, SW; Kellokumpu-Lehtinen, P; Kinnula, VL; Martikainen, PM; Peltoniemi, M; Soini, Y; Tammela, TL | 1 |
Kanda, S; Kanetake, H; Miyata, Y | 1 |
Dizdaroglu, M; Hiai, H; Mori, T; Toyokuni, S | 1 |
Hamburger, AW; Mishra, S | 1 |
Campbell, DL; Carbonaro-Hall, D; Hall, F; Pelech, S; Sanghera, J; Warburton, D; Williams, R; Wu, F | 1 |
Abe, H; Chihara, K; Kaji, H; Mizuno, I; Okimura, Y; Takahashi, T; Takahashi, Y; Uchiyama, T | 1 |
Burrow, CR; Ratovitski, EA | 1 |
Bander, NH; Feldman, M; Hicklin, DJ; Prewett, M; Rothman, M; Waksal, H | 1 |
Barry, G; Crowe, PD; De Souza, EB; Fan, J; Kelner, GS; Ling, N; Liu, C; Liu, XJ; Maki, RA; Manu, F | 1 |
Horiguchi, A; Marumo, K; Murai, M; Oya, M | 1 |
3 review(s) available for tyrosine and Cancer of Kidney
Article | Year |
---|---|
Severe tyrosine-kinase inhibitor induced liver injury in metastatic renal cell carcinoma patients: two case reports assessed for causality using the updated RUCAM and review of the literature.
Topics: Carcinoma, Renal Cell; Chemical and Drug Induced Liver Injury; Chemical and Drug Induced Liver Injury, Chronic; Humans; Kidney Neoplasms; Tyrosine | 2022 |
Isolated Pituitary Metastasis of Renal Cell Carcinoma: A Case Report and Systematic Review of the Literature.
Topics: Carcinoma, Renal Cell; Female; Humans; Kidney Neoplasms; Middle Aged; Pituitary Neoplasms; Sunitinib; Tyrosine | 2022 |
Adjuvant Therapy in High-Risk Renal Cell Cancer: A Systematic Review and Meta-analysis.
Topics: Aged; Aged, 80 and over; Carcinoma, Renal Cell; Chemotherapy, Adjuvant; Combined Modality Therapy; Disease-Free Survival; Female; Humans; Kidney Neoplasms; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Nephrectomy; Prognosis; Proportional Hazards Models; Randomized Controlled Trials as Topic; Risk Assessment; Survival Analysis; Treatment Outcome; Tyrosine; Vascular Endothelial Growth Factor A | 2019 |
1 trial(s) available for tyrosine and Cancer of Kidney
Article | Year |
---|---|
Faecal microbiota transplantation for the treatment of diarrhoea induced by tyrosine-kinase inhibitors in patients with metastatic renal cell carcinoma.
Topics: Aged; Carcinoma, Renal Cell; Diarrhea; Double-Blind Method; Drug Therapy; Dysbiosis; Enzyme Inhibitors; Fecal Microbiota Transplantation; Feces; Female; Gastrointestinal Microbiome; Humans; Kidney Neoplasms; Male; Middle Aged; Tissue Donors; Tyrosine | 2020 |
27 other study(ies) available for tyrosine and Cancer of Kidney
Article | Year |
---|---|
Identification of HGD and GSTZ1 as Biomarkers Involved Metabolic Reprogramming in Kidney Renal Clear Cell Carcinoma.
Topics: Biomarkers, Tumor; Carcinoma, Renal Cell; Dioxygenases; Female; Glutathione Transferase; Homogentisate 1,2-Dioxygenase; Humans; Kidney; Kidney Neoplasms; Male; Tyrosine | 2022 |
Activating mTOR Mutations Are Detrimental in Nutrient-Poor Conditions.
Topics: Carcinoma, Renal Cell; Humans; Kidney Neoplasms; Mutation; Nutrients; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; TOR Serine-Threonine Kinases; Tyrosine | 2022 |
Site-specific patterns of early response to nivolumab plus ipilimumab therapy in advanced renal cell carcinoma patients compared with tyrosine-kinase inhibitors.
Topics: Carcinoma, Renal Cell; Humans; Ipilimumab; Kidney Neoplasms; Lung Neoplasms; Nivolumab; Tyrosine | 2022 |
SEOM SOGUG clinical guideline for treatment of kidney cancer (2022).
Topics: Carcinoma, Renal Cell; Female; Humans; Kidney Neoplasms; Male; Nivolumab; Quality of Life; Sunitinib; Tyrosine | 2023 |
Characterization of the expression of LAT1 as a prognostic indicator and a therapeutic target in renal cell carcinoma.
Topics: Benzoxazoles; Biomarkers, Tumor; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Movement; Cell Proliferation; Female; Humans; Kidney Neoplasms; Large Neutral Amino Acid-Transporter 1; Male; Middle Aged; Prognosis; Progression-Free Survival; Retrospective Studies; Tyrosine | 2019 |
PSMA PET/CT for tyrosine-kinase inhibitor monitoring in metastatic renal cell carcinoma.
Topics: Carcinoma, Renal Cell; Edetic Acid; Glutamate Carboxypeptidase II; Humans; Kidney Neoplasms; Male; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Tyrosine | 2020 |
MicroRNA-363 inhibits angiogenesis, proliferation, invasion, and migration of renal cell carcinoma via inactivation of the Janus tyrosine kinases 2-signal transducers and activators of transcription 3 axis by suppressing growth hormone receptor gene.
Topics: Adult; Angiogenesis Inducing Agents; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Proliferation; Female; Gene Expression Regulation, Neoplastic; Humans; Janus Kinase 2; Kidney Neoplasms; Male; MicroRNAs; Middle Aged; Receptors, Somatotropin; Signal Transduction; STAT3 Transcription Factor; Tyrosine | 2019 |
Inhibition of PPARα induces cell cycle arrest and apoptosis, and synergizes with glycolysis inhibition in kidney cancer cells.
Topics: Apoptosis; Carcinoma, Renal Cell; Cell Cycle Checkpoints; Cell Line; Cell Line, Tumor; Cell Survival; Cyclin D1; Cyclin-Dependent Kinase 4; Deoxyglucose; G1 Phase; Glucose; Glycolysis; Humans; Immunoblotting; Immunohistochemistry; Kidney Neoplasms; Oxazoles; PPAR alpha; Proto-Oncogene Proteins c-myc; Resting Phase, Cell Cycle; RNA Interference; Tyrosine | 2013 |
The fate of tyrosinaemic Hungarian patients before the NTBC aera.
Topics: 4-Hydroxyphenylpyruvate Dioxygenase; Carcinoma, Hepatocellular; Carcinoma, Renal Cell; Child, Preschool; Cyclohexanones; Enzyme Inhibitors; Fatal Outcome; Homozygote; Humans; Hungary; Hydrolases; Kidney Neoplasms; Liver Neoplasms; Male; Nitrobenzoates; Treatment Outcome; Tyrosine; Tyrosinemias | 2013 |
Early response monitoring of receptor tyrosine kinase inhibitor therapy in metastatic renal cell carcinoma using [F-18]fluorothymidine-positron emission tomography-magnetic resonance.
Topics: Antineoplastic Agents; Carcinoma, Renal Cell; Contrast Media; Diffusion Magnetic Resonance Imaging; Gadolinium DTPA; Humans; Image Enhancement; Indoles; Kidney Neoplasms; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Protein Kinase Inhibitors; Pyrroles; Radiopharmaceuticals; Sunitinib; Tomography, X-Ray Computed; Treatment Outcome; Tyrosine | 2014 |
PPARα inhibition modulates multiple reprogrammed metabolic pathways in kidney cancer and attenuates tumor growth.
Topics: Animals; Carcinoma, Renal Cell; Cell Cycle Checkpoints; Cell Line, Tumor; Epithelial Cells; Gene Expression Regulation, Neoplastic; Humans; Kidney Neoplasms; Kidney Tubules; Metabolic Networks and Pathways; Mice; Mice, Nude; Organ Specificity; Oxazoles; Phosphorylation; PPAR alpha; Proto-Oncogene Proteins c-myc; RNA, Small Interfering; Signal Transduction; Tyrosine; Xenograft Model Antitumor Assays | 2015 |
Pro-Tumorigenic Phosphorylation of p120 Catenin in Renal and Breast Cancer.
Topics: Blotting, Western; Breast Neoplasms; Carcinoma, Renal Cell; Catenins; Cell Transformation, Neoplastic; Delta Catenin; Female; Humans; Immunoenzyme Techniques; Immunoprecipitation; Kidney Neoplasms; Phosphoproteins; Phosphorylation; Protein Binding; Serine; Threonine; Tissue Array Analysis; Tumor Cells, Cultured; Tyrosine | 2015 |
Tyrosine Kinase Signaling in Clear Cell and Papillary Renal Cell Carcinoma Revealed by Mass Spectrometry-Based Phosphotyrosine Proteomics.
Topics: Carcinoma, Papillary; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Survival; ErbB Receptors; Extracellular Matrix; Humans; Kidney Neoplasms; Mass Spectrometry; Phosphorylation; Phosphotyrosine; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Proteomics; Receptor Protein-Tyrosine Kinases; Signal Transduction; Tyrosine | 2016 |
Study of molecule variations in renal tumor based on confocal micro-Raman spectroscopy.
Topics: Adult; Aged; Female; Humans; Kidney Neoplasms; Male; Middle Aged; Oxygen; Principal Component Analysis; Spectrum Analysis, Raman; Tyrosine | 2013 |
VEGF receptor-2 Y951 signaling and a role for the adapter molecule TSAd in tumor angiogenesis.
Topics: Actins; Adaptor Proteins, Signal Transducing; Amino Acid Sequence; Animals; Binding Sites; Cell Line, Tumor; Cells, Cultured; Endothelial Cells; Fibrosarcoma; Humans; Kidney Neoplasms; Mice; Molecular Sequence Data; Neovascularization, Pathologic; Phosphorylation; RNA, Small Interfering; Signal Transduction; Stem Cells; Tyrosine; Vascular Endothelial Growth Factor Receptor-2 | 2005 |
Antioxidant enzymes in renal cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Antioxidants; Apoptosis; Blotting, Western; Carcinoma, Renal Cell; Catalase; Female; Glutamate-Cysteine Ligase; Humans; Immunohistochemistry; In Situ Nick-End Labeling; Kidney Neoplasms; Male; Middle Aged; Superoxide Dismutase; Thioredoxin-Disulfide Reductase; Thioredoxins; Tyrosine | 2006 |
PAR-type thrombin receptors in renal carcinoma cells: PAR1-mediated EGFR activation promotes cell migration.
Topics: Cell Line, Tumor; Cell Movement; Dipeptides; Enzyme Inhibitors; Epidermal Growth Factor; ErbB Receptors; Humans; Kidney Neoplasms; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Oligopeptides; Phosphorylation; Pyrroles; Quinazolines; Receptor, PAR-1; Thrombin; Tyrosine; Tyrphostins | 2006 |
Oxidative/nitrosative stress and peroxiredoxin 2 are associated with grade and prognosis of human renal carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Blotting, Western; Carcinoma, Renal Cell; Humans; Immunohistochemistry; Kidney Neoplasms; Middle Aged; Neoplasm Staging; Nephrectomy; Oxidative Stress; Peroxidases; Peroxiredoxins; Prognosis; Survival Analysis; Tyrosine | 2006 |
Presence of phosphorylated hepatocyte growth factor receptor/c-Met is associated with tumor progression and survival in patients with conventional renal cell carcinoma.
Topics: Carcinoma, Renal Cell; Disease Progression; Female; Humans; Kidney Neoplasms; Male; Middle Aged; Phosphorylation; Proto-Oncogene Proteins c-met; Retrospective Studies; Tumor Cells, Cultured; Tyrosine | 2006 |
Treatment of Wistar rats with a renal carcinogen, ferric nitrilotriacetate, causes DNA-protein cross-linking between thymine and tyrosine in their renal chromatin.
Topics: Adenocarcinoma; Animals; Carcinogens; Chromatin; Cross-Linking Reagents; DNA Damage; DNA, Neoplasm; Ferric Compounds; Kidney; Kidney Neoplasms; Kidney Tubules, Proximal; Male; Neoplasm Proteins; Nitrilotriacetic Acid; Rats; Rats, Wistar; Thymine; Tyrosine | 1995 |
O-phospho-L-tyrosine inhibits cellular growth by activating protein tyrosine phosphatases.
Topics: Breast Neoplasms; Carcinoma, Renal Cell; Cell Death; Cell Division; Doxorubicin; Enzyme Activation; Epidermal Growth Factor; ErbB Receptors; Etoposide; Humans; Kidney Neoplasms; Neoplasm Proteins; Phosphorylation; Phosphotyrosine; Protein Tyrosine Phosphatases; S Phase; Sensitivity and Specificity; Tumor Cells, Cultured; Tyrosine | 1993 |
Identification of a human epidermal growth factor receptor-associated protein kinase as a new member of the mitogen-activated protein kinase/extracellular signal-regulated protein kinase family.
Topics: Amino Acid Sequence; Animals; Antibodies; Blotting, Western; Calcium-Calmodulin-Dependent Protein Kinases; Carcinoma, Squamous Cell; Chromatography, Ion Exchange; Electrophoresis, Polyacrylamide Gel; ErbB Receptors; Humans; Isoenzymes; Kidney Neoplasms; Molecular Sequence Data; Molecular Weight; Phosphotyrosine; Protein Kinases; Protein-Tyrosine Kinases; Proteins; Rats; Signal Transduction; Tumor Cells, Cultured; Tyrosine; Wilms Tumor | 1993 |
Leptin induces tyrosine phosphorylation of cellular proteins including STAT-1 in human renal adenocarcinoma cells, ACHN.
Topics: Adenocarcinoma; Blotting, Western; DNA-Binding Proteins; Humans; Kidney Neoplasms; Leptin; Obesity; Phosphorylation; Proteins; Recombinant Proteins; STAT1 Transcription Factor; Trans-Activators; Tumor Cells, Cultured; Tyrosine | 1996 |
Midkine stimulates Wilms' tumor cell proliferation via its signaling receptor.
Topics: Animals; Base Sequence; Carrier Proteins; Cell Division; COS Cells; Cytokines; DNA Primers; Humans; Kidney Neoplasms; Kinetics; Midkine; Mitogens; Molecular Weight; Neoplasm Proteins; Phosphorylation; Receptors, Cell Surface; Signal Transduction; Tumor Cells, Cultured; Tyrosine; Wilms Tumor | 1997 |
Mouse-human chimeric anti-epidermal growth factor receptor antibody C225 inhibits the growth of human renal cell carcinoma xenografts in nude mice.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Carcinoma, Renal Cell; Cell Division; Cetuximab; Disease Models, Animal; ErbB Receptors; Humans; Kidney Neoplasms; Mice; Mice, Nude; Neoplasm Transplantation; Phosphorylation; Recombinant Fusion Proteins; Transplantation, Heterologous; Tumor Cells, Cultured; Tyrosine | 1998 |
Nephroblastoma overexpressed gene (NOV) codes for a growth factor that induces protein tyrosine phosphorylation.
Topics: 3T3 Cells; Amino Acid Sequence; Animals; Cell Division; Cloning, Molecular; Connective Tissue Growth Factor; Dexamethasone; DNA, Complementary; Gene Expression Regulation, Neoplastic; Humans; Immediate-Early Proteins; Intercellular Signaling Peptides and Proteins; Kidney Neoplasms; Mice; Molecular Sequence Data; Nephroblastoma Overexpressed Protein; Oncogene Proteins, Viral; Phosphorylation; Proto-Oncogene Proteins; Rats; Recombinant Proteins; RNA, Messenger; Sequence Homology, Amino Acid; Tumor Cells, Cultured; Tyrosine; Wilms Tumor | 1999 |
STAT3, but not ERKs, mediates the IL-6-induced proliferation of renal cancer cells, ACHN and 769P.
Topics: Antibodies, Monoclonal; Apoptosis; Cell Division; DNA-Binding Proteins; Enzyme Activation; Enzyme Inhibitors; Flavonoids; Humans; Interleukin-6; Intracellular Membranes; Kidney Neoplasms; MAP Kinase Kinase 1; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; Phosphorylation; Protein Serine-Threonine Kinases; Receptors, Interleukin-6; Signal Transduction; STAT3 Transcription Factor; Trans-Activators; Tumor Cells, Cultured; Tyrosine; Tyrphostins | 2002 |